Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections.
作者信息
Marks Laura R, Liang Stephen Y, Durkin Michael J, Martin Marlene, White Katie D, See Isaac
机构信息
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO.
Division of Hospital Medicine, Zuckerberg San Francisco General Hospital and the Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA.
出版信息
J Addict Med. 2020 Dec;14(6):518. doi: 10.1097/ADM.0000000000000650.
Abstract
摘要
相似文献
1
Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections.用于阿片类物质使用障碍的药物对侵袭性感染患者显示出明显益处。
J Addict Med. 2020 Dec;14(6):518. doi: 10.1097/ADM.0000000000000650.
2
Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.COVID-19 大流行期间阿片类药物使用障碍的阿片类镇痛药和丁丙诺啡的处方
JAMA Netw Open. 2021 Apr 1;4(4):e216147. doi: 10.1001/jamanetworkopen.2021.6147.
3
Use and misuse of opioid agonists in opioid addiction.阿片类药物成瘾中阿片类激动剂的使用和滥用。
Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.
4
Treatment of pain in patients taking buprenorphine for opioid addiction #221.对服用丁丙诺啡治疗阿片类药物成瘾患者的疼痛治疗#221。
J Palliat Med. 2012 May;15(5):613-4. doi: 10.1089/jpm.2012.9591.
5
Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.因阿片类物质使用障碍而维持使用丁丙诺啡治疗的患者，在围手术期应继续使用丁丙诺啡。
Pain Med. 2019 Mar 1;20(3):425-428. doi: 10.1093/pm/pny019.
6
Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?消除阿片类药物使用障碍治疗的一个障碍：这足够了吗？
JAMA. 2021 Mar 23;325(12):1147-1148. doi: 10.1001/jama.2021.0958.
7
Buprenorphine: a more accessible treatment for opioid dependence.丁丙诺啡：一种更易获得的阿片类药物依赖治疗方法。
JAAPA. 2010 Sep;23(9):40-3. doi: 10.1097/01720610-201009000-00008.
8
Buprenorphine to treat opioid use disorder: A practical guide.丁丙诺啡治疗阿片类物质使用障碍：实用指南。
J Fam Pract. 2018 Jun;67(9):544-548.
9
In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.简而言之：丁丙诺啡/纳洛酮（Zubsolv）用于治疗阿片类药物依赖。
Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.
10
Overview of Drugs Used to Treat Opioid Use Disorder.用于治疗阿片类物质使用障碍的药物概述。
Am J Nurs. 2018 Aug;118(8):25. doi: 10.1097/01.NAJ.0000544161.29445.db.
引用本文的文献
1
Low Knowledge of HIV PrEP Within a Midwestern US Cohort of Persons who Inject Drugs.美国中西部注射吸毒人群队列中对HIV暴露前预防（PrEP）的认知水平较低。
Open Forum Infect Dis. 2021 Nov 10;9(1):ofab541. doi: 10.1093/ofid/ofab541. eCollection 2022 Jan.
2
Use of ICD-10 Codes for Identification of Injection Drug Use-Associated Infective Endocarditis Is Nonspecific and Obscures Critical Findings on Impact of Medications for Opioid Use Disorder.使用国际疾病分类第十版（ICD - 10）编码来识别注射吸毒相关感染性心内膜炎并不具有特异性，且掩盖了药物对阿片类物质使用障碍影响的关键发现。
Open Forum Infect Dis. 2020 Sep 9;7(10):ofaa414. doi: 10.1093/ofid/ofaa414. eCollection 2020 Oct.
3
Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply.用于阿片类物质使用障碍的药物对侵袭性感染患者显示出明显益处：回复信。
J Addict Med. 2020 Dec;14(6):518-519. doi: 10.1097/ADM.0000000000000651.
本文引用的文献
1
Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs.注射吸毒相关感染性心内膜炎患者的长期结局。
J Addict Med. 2020 Jul/Aug;14(4):282-286. doi: 10.1097/ADM.0000000000000572.
2
Addiction Medicine Consultations Reduce Readmission Rates for Patients With Serious Infections From Opioid Use Disorder.成瘾医学咨询可降低因阿片类药物使用障碍导致严重感染的患者的再入院率。
Clin Infect Dis. 2019 May 17;68(11):1935-1937. doi: 10.1093/cid/ciy924.
3
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.阿片类药物替代治疗期间及之后的死亡风险：队列研究的系统评价和荟萃分析
BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550.
4
Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.丁丙诺啡用于住院阿片类药物依赖患者的治疗：一项随机临床试验。
JAMA Intern Med. 2014 Aug;174(8):1369-76. doi: 10.1001/jamainternmed.2014.2556.
Zotero 插件